IS5166A - Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru - Google Patents

Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru

Info

Publication number
IS5166A
IS5166A IS5166A IS5166A IS5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A IS 5166 A IS5166 A IS 5166A
Authority
IS
Iceland
Prior art keywords
phenylpyrrolidin
indole
dichloro
oxo
carboxylic acid
Prior art date
Application number
IS5166A
Other languages
English (en)
Inventor
Cimarosti Zadeo
Maragni Paolo
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of IS5166A publication Critical patent/IS5166A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5166A 1997-03-05 1999-08-27 Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru IS5166A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound
PCT/EP1998/001146 WO1998039327A1 (en) 1997-03-05 1998-03-03 Crystalline hydrated sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid

Publications (1)

Publication Number Publication Date
IS5166A true IS5166A (is) 1999-08-27

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5166A IS5166A (is) 1997-03-05 1999-08-27 Kristallað vatnað natríumsalt af (E)-4,6-díklóró-3-(2-oxó-1-fenýlpýrrólidín-3-ýliden metýl)-1h-indól-2-karboxýlsýru

Country Status (29)

Country Link
EP (1) EP0966463A1 (is)
JP (1) JP2001513796A (is)
KR (1) KR20000075907A (is)
CN (1) CN1249750A (is)
AP (1) AP9901637A0 (is)
AR (1) AR011178A1 (is)
AU (1) AU6825198A (is)
BG (1) BG103779A (is)
BR (1) BR9808305A (is)
CA (1) CA2282851A1 (is)
CO (1) CO4940415A1 (is)
EA (1) EA199900710A1 (is)
EE (1) EE9900387A (is)
GB (1) GB9704498D0 (is)
HR (1) HRP980114A2 (is)
HU (1) HUP0002109A2 (is)
ID (1) ID24207A (is)
IL (1) IL131489A0 (is)
IS (1) IS5166A (is)
NO (1) NO994303L (is)
NZ (1) NZ337315A (is)
OA (1) OA11154A (is)
PE (1) PE51399A1 (is)
PL (1) PL335652A1 (is)
SK (1) SK119699A3 (is)
TR (1) TR199902117T2 (is)
WO (1) WO1998039327A1 (is)
YU (1) YU43499A (is)
ZA (1) ZA981791B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
CA3067162A1 (en) 2017-06-12 2018-12-20 Glytech Llc. Composition and method for treatment or depression and psychosis in humans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
NO994303L (no) 1999-11-03
SK119699A3 (en) 2000-05-16
JP2001513796A (ja) 2001-09-04
KR20000075907A (ko) 2000-12-26
BR9808305A (pt) 2000-05-16
AU6825198A (en) 1998-09-22
WO1998039327A1 (en) 1998-09-11
PL335652A1 (en) 2000-05-08
YU43499A (sh) 2000-12-28
CN1249750A (zh) 2000-04-05
EP0966463A1 (en) 1999-12-29
AP9901637A0 (en) 1999-09-30
ID24207A (id) 2000-07-13
EA199900710A1 (ru) 2000-04-24
CO4940415A1 (es) 2000-07-24
NZ337315A (en) 2001-02-23
PE51399A1 (es) 1999-06-07
AR011178A1 (es) 2000-08-02
EE9900387A (et) 2000-04-17
HRP980114A2 (en) 1998-12-31
TR199902117T2 (xx) 2000-03-21
HUP0002109A2 (hu) 2001-04-28
OA11154A (en) 2003-04-16
ZA981791B (en) 1999-09-03
NO994303D0 (no) 1999-09-03
GB9704498D0 (en) 1997-04-23
IL131489A0 (en) 2001-01-28
BG103779A (en) 2000-06-30
CA2282851A1 (en) 1998-09-11

Similar Documents

Publication Publication Date Title
DK0991641T3 (da) Krystallinsk form af omeprazol-natriumsalt
DE59912742D1 (de) Substituierte pyrazolderivate
PT1077957E (pt) Derivados do acido oxi-iminoalcanoico
NO20005084D0 (no) Heterosykliske glysyl <beta>-alanin derivater som vitronektinantagonister
NO20013665D0 (no) Kaliumsalt av (S)-omeprazol
EE200000720A (et) Uus 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
DK1163207T3 (da) Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
DE69900356D1 (de) Nitro-Isoharnstoffderivate
NO20003451D0 (no) 2,3-substituerte indolforbindelser som cox-2 inhibitorer
IS5772A (is) Þalazín (phthalazine) afleiður af fosfódíesterasa4 lötum
NO20013684D0 (no) Substituerte fenetylaminderivater
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
DK1189583T3 (da) Indolderivater
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
IS6434A (is) Nýjar indól afleiður
NO20020306D0 (no) Indolderivater
EE9900387A (et) (E)-4,6-dikloro-3-(2-okso-1-fenüülpürrolidiin-3-ülideenmetüül)-1H-indool-2-karboksü ülhappe naatriumisoola kristallhüdraat
NO20002904D0 (no) (E)-3-[1-N-butyl-5-[2-(2-karboksylfenyl)metoksy-4-klorfenyl]- 1H-pyrazol-4-yl]-2-[(5-metoksy-2,3-dihydrobenzofuran-6-yl)methyl]- prop-2-ensyre monoagrininsalt
NO994386D0 (no) 2-substituerte benzoylcykloalkyl-1-karboksylsyrederivater
IT1307734B1 (it) Cartuccia per dialisi contenente bicarbonato di sodio.
DK1140984T3 (da) Selektive inhibitorer af MMP-12
HK1022899A (en) Crystalline hydrated sodium salt of (e)-4, 6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid
ATE414059T1 (de) Kristalline form des natriumsalzes von 5-chlor-2- methoxy-n-(2-(4-methoxy-3- methylaminothiocarbonylaminosulfonylphenyl)ethy )bnzamid
DK1012143T3 (da) Fremgangsmåde til fremstilling af 1-phenylpyrazolin-3-carboxylsyrederivater
DK0989113T3 (da) Fremgangsmåde til fremstilling af 2-aminomalonsyrederivater